| - GRCh37:
- Chr2:220431745
- GRCh38:
- Chr2:219567023
| OBSL1 | W647C | 3M syndrome 2 | Uncertain significance | criteria provided, single submitter |
| - GRCh37:
- Chr2:220432798-220432799
- GRCh38:
- Chr2:219568076-219568077
| OBSL1 | V421fs | 3M syndrome 2 | Pathogenic | criteria provided, single submitter |
| - GRCh37:
- Chr2:220416377-220416378
- GRCh38:
- Chr2:219551655-219551656
| OBSL1 | K1853fs | 3M syndrome 2 | Likely pathogenic (Mar 1, 2023) | criteria provided, single submitter |
| - GRCh37:
- Chr2:220422239
- GRCh38:
- Chr2:219557517
| OBSL1 | G1298S | 3M syndrome 2, Inborn genetic diseases | Uncertain significance (Apr 5, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:220422825-220422826
- GRCh38:
- Chr2:219558103-219558104
| OBSL1 | V1171fs | 3M syndrome 2 | Likely pathogenic (Jan 1, 2023) | criteria provided, single submitter |
| - GRCh37:
- Chr2:220428149
- GRCh38:
- Chr2:219563427
| OBSL1 | Q870* | 3M syndrome 2 | Likely pathogenic (Jan 4, 2023) | criteria provided, single submitter |
| - GRCh37:
- Chr2:220422717-220422732
- GRCh38:
- Chr2:219557995-219558010
| OBSL1 | P1203fs | 3M syndrome 2 | Likely pathogenic (Dec 21, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:220435034
- GRCh38:
- Chr2:219570312
| OBSL1 | Y308fs | 3M syndrome 2 | Likely pathogenic (Oct 15, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:220430050-220430051
- GRCh38:
- Chr2:219565328-219565329
| OBSL1 | | 3M syndrome 2 | Likely pathogenic (Sep 1, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:220435527-220435528
- GRCh38:
- Chr2:219570805-219570806
| OBSL1 | A143fs | 3M syndrome 2 | Likely pathogenic (Aug 31, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:220432983-220432984
- GRCh38:
- Chr2:219568261-219568262
| OBSL1 | V359fs | 3M syndrome 2 | Pathogenic (May 22, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:220435496-220435497
- GRCh38:
- Chr2:219570774-219570775
| OBSL1 | L154fs | OBSL1-related condition, not provided, 3M syndrome 2
| Pathogenic (Jan 9, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:220416343-220416344
- GRCh38:
- Chr2:219551621-219551622
| OBSL1 | S1864fs | 3M syndrome 2 | Likely pathogenic (Apr 18, 2023) | criteria provided, single submitter |
| - GRCh37:
- Chr2:220421427
- GRCh38:
- Chr2:219556705
| OBSL1 | L1362fs | 3M syndrome 2 | Likely pathogenic (Aug 1, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr2:220415596-220415597
- GRCh38:
- Chr2:219550874-219550875
| OBSL1 | | 3M syndrome 2, not provided | Benign (Sep 5, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:220416967
- GRCh38:
- Chr2:219552245
| OBSL1 | | 3M syndrome 2, not provided | Benign (Sep 5, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:220416803
- GRCh38:
- Chr2:219552081
| OBSL1 | | not provided, 3M syndrome 2 | Benign (Sep 5, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:220421479
- GRCh38:
- Chr2:219556757
| OBSL1 | | 3M syndrome 2, not provided | Benign (Sep 5, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:220427429
- GRCh38:
- Chr2:219562707
| OBSL1 | | 3M syndrome 2, not provided | Benign (Sep 5, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:220430207
- GRCh38:
- Chr2:219565485
| OBSL1 | D722fs | 3M syndrome 2 | Pathogenic | criteria provided, single submitter |
| - GRCh37:
- Chr2:220428381
- GRCh38:
- Chr2:219563659
| OBSL1 | | not provided, 3M syndrome 2 | Benign (Sep 5, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:220432709
- GRCh38:
- Chr2:219567987
| OBSL1 | | not provided, 3M syndrome 2 | Benign (Nov 3, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:220428179-220428180
- GRCh38:
- Chr2:219563457-219563458
| OBSL1 | P860S | not provided, 3M syndrome 2 | Benign/Likely benign (Oct 24, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:220430044
- GRCh38:
- Chr2:219565322
| OBSL1 | P776R | 3M syndrome 2 | Uncertain significance (Oct 17, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:220422137
- GRCh38:
- Chr2:219557415
| OBSL1 | R1332W | Inborn genetic diseases, not provided, 3M syndrome 2
| Uncertain significance (Feb 22, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:220420931
- GRCh38:
- Chr2:219556209
| OBSL1 | R1474* | 3M syndrome 2, not specified, not provided
| Uncertain significance (Jul 11, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:220423116
- GRCh38:
- Chr2:219558394
| OBSL1 | R1098C | not provided, 3M syndrome 2 | Uncertain significance (Jul 3, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:220432785-220432786
- Chr2:220435119
- GRCh38:
- Chr2:219568063-219568064
- Chr2:219570397
| OBSL1, OBSL1 | T425fs, W279* | 3M syndrome 2 | Pathogenic (May 31, 2019) | no assertion criteria provided |
| - GRCh37:
- Chr2:220435919-220435920
- GRCh38:
- Chr2:219571197-219571198
| OBSL1 | C13fs | 3M syndrome 2, not provided | Pathogenic/Likely pathogenic (Jul 15, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:220428122
- GRCh38:
- Chr2:219563400
| OBSL1 | C879fs | 3M syndrome 2 | Likely pathogenic (Feb 25, 2019) | criteria provided, single submitter |
| | | | 3M syndrome 2 | Pathogenic (Apr 14, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr2:220435190
- GRCh38:
- Chr2:219570468
| OBSL1 | | 3M syndrome 2 | Uncertain significance (Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr2:220435048
- GRCh38:
- Chr2:219570326
| OBSL1 | V303M | 3M syndrome 2 | Uncertain significance (Mar 30, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr2:220432531
- GRCh38:
- Chr2:219567809
| OBSL1 | | not provided, 3M syndrome 2 | Conflicting interpretations of pathogenicity (Oct 18, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr2:220432169
- GRCh38:
- Chr2:219567447
| OBSL1 | R555W | not provided, 3M syndrome 2 | Conflicting interpretations of pathogenicity (Oct 16, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr2:220432099
- GRCh38:
- Chr2:219567377
| OBSL1 | P578L | 3M syndrome 2 | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr2:220428259
- GRCh38:
- Chr2:219563537
| OBSL1 | R833Q | Inborn genetic diseases, 3M syndrome 2 | Uncertain significance (Apr 12, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:220428119
- GRCh38:
- Chr2:219563397
| OBSL1 | V880I | not provided, 3M syndrome 2 | Uncertain significance (Aug 26, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:220422760
- GRCh38:
- Chr2:219558038
| OBSL1 | V1192A | 3M syndrome 2 | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr2:220422744
- GRCh38:
- Chr2:219558022
| OBSL1 | | 3M syndrome 2 | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr2:220422653
- GRCh38:
- Chr2:219557931
| OBSL1 | R1228G | 3M syndrome 2 | Uncertain significance (Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr2:220421360
- GRCh38:
- Chr2:219556638
| OBSL1 | | 3M syndrome 2 | Uncertain significance (Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr2:220421329
- GRCh38:
- Chr2:219556607
| OBSL1 | N1395D | 3M syndrome 2 | Uncertain significance (Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr2:220421318
- GRCh38:
- Chr2:219556596
| OBSL1 | | 3M syndrome 2 | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr2:220421310
- GRCh38:
- Chr2:219556588
| OBSL1 | P1401L | not provided, 3M syndrome 2 | Conflicting interpretations of pathogenicity (Oct 16, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr2:220417323
- GRCh38:
- Chr2:219552601
| OBSL1 | T1748M | Inborn genetic diseases, not provided, 3M syndrome 2
| Conflicting interpretations of pathogenicity (Feb 22, 2023) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr2:220417321
- GRCh38:
- Chr2:219552599
| OBSL1 | G1749R | not provided, Inborn genetic diseases, 3M syndrome 2
| Uncertain significance (Sep 12, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:220436027
- GRCh38:
- Chr2:219571305
| OBSL1 | | 3M syndrome 2 | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr2:220436013
- GRCh38:
- Chr2:219571291
| OBSL1 | | 3M syndrome 2 | Uncertain significance (Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr2:220436005
- GRCh38:
- Chr2:219571283
| OBSL1 | | 3M syndrome 2 | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr2:220435989
- GRCh38:
- Chr2:219571267
| OBSL1 | | 3M syndrome 2 | Uncertain significance (Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr2:220435975
- GRCh38:
- Chr2:219571253
| OBSL1 | | 3M syndrome 2 | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr2:220435966
- GRCh38:
- Chr2:219571244
| OBSL1 | | 3M syndrome 2 | Likely benign (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr2:220434962
- GRCh38:
- Chr2:219570240
| OBSL1 | | 3M syndrome 2 | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr2:220432982
- GRCh38:
- Chr2:219568260
| OBSL1 | | 3M syndrome 2 | Uncertain significance (Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr2:220432923
- GRCh38:
- Chr2:219568201
| OBSL1 | R379Q | 3M syndrome 2 | Uncertain significance (Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr2:220431836
- GRCh38:
- Chr2:219567114
| OBSL1 | R617L | Inborn genetic diseases, 3M syndrome 2 | Uncertain significance (Jul 28, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:220431775
- GRCh38:
- Chr2:219567053
| OBSL1 | | 3M syndrome 2 | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr2:220427371
- GRCh38:
- Chr2:219562649
| OBSL1 | | not provided, 3M syndrome 2 | Conflicting interpretations of pathogenicity (Oct 5, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr2:220427346
- GRCh38:
- Chr2:219562624
| OBSL1 | V911M | not provided, 3M syndrome 2 | Uncertain significance (Dec 26, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:220427286
- GRCh38:
- Chr2:219562564
| OBSL1 | W931G | not provided, Inborn genetic diseases, 3M syndrome 2
| Uncertain significance (Oct 28, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:220427219
- GRCh38:
- Chr2:219562497
| OBSL1 | R953H | 3M syndrome 2 | Uncertain significance (Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr2:220422292
- GRCh38:
- Chr2:219557570
| OBSL1 | R1280Q | 3M syndrome 2, not provided | Conflicting interpretations of pathogenicity (Aug 21, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr2:220422278
- GRCh38:
- Chr2:219557556
| OBSL1 | G1285R | not provided, 3M syndrome 2, Inborn genetic diseases
| Uncertain significance (Sep 1, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:220420932
- GRCh38:
- Chr2:219556210
| OBSL1 | | not provided, 3M syndrome 2 | Conflicting interpretations of pathogenicity (Aug 2, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr2:220420922
- GRCh38:
- Chr2:219556200
| OBSL1 | A1477T | not provided, 3M syndrome 2 | Conflicting interpretations of pathogenicity (Dec 27, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr2:220417246
- GRCh38:
- Chr2:219552524
| LOC129935660, OBSL1 | | 3M syndrome 2, not provided | Benign/Likely benign (Nov 3, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:220416447
- GRCh38:
- Chr2:219551725
| OBSL1 | | not provided, 3M syndrome 2 | Conflicting interpretations of pathogenicity (Aug 23, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr2:220416341
- GRCh38:
- Chr2:219551619
| OBSL1 | | not provided, 3M syndrome 2 | Conflicting interpretations of pathogenicity (Jun 30, 2021) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr2:220435909
- GRCh38:
- Chr2:219571187
| OBSL1 | R16S | 3M syndrome 2 | Uncertain significance (Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr2:220435813
- GRCh38:
- Chr2:219571091
| OBSL1 | G48S | not provided, 3M syndrome 2 | Uncertain significance (Sep 27, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:220435753
- GRCh38:
- Chr2:219571031
| OBSL1 | G68S | not provided, 3M syndrome 2 | Uncertain significance (Jul 6, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:220435687
- GRCh38:
- Chr2:219570965
| OBSL1 | A90T | not provided, 3M syndrome 2 | Uncertain significance (Jul 15, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:220432908
- GRCh38:
- Chr2:219568186
| OBSL1 | R384P | 3M syndrome 2 | Uncertain significance (Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr2:220432892
- GRCh38:
- Chr2:219568170
| OBSL1 | | not provided, 3M syndrome 2 | Conflicting interpretations of pathogenicity (Jul 26, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr2:220432864
- GRCh38:
- Chr2:219568142
| OBSL1 | I399V | 3M syndrome 2 | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr2:220432831
- GRCh38:
- Chr2:219568109
| OBSL1 | Y410H | 3M syndrome 2, not provided | Conflicting interpretations of pathogenicity (Mar 14, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr2:220432822
- GRCh38:
- Chr2:219568100
| OBSL1 | E413K | 3M syndrome 2 | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr2:220431720
- GRCh38:
- Chr2:219566998
| OBSL1 | S656G | 3M syndrome 2 | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr2:220431583
- GRCh38:
- Chr2:219566861
| OBSL1 | | not provided, 3M syndrome 2 | Conflicting interpretations of pathogenicity (Sep 24, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr2:220431582
- GRCh38:
- Chr2:219566860
| OBSL1 | V702M | not provided, 3M syndrome 2 | Uncertain significance (Jul 15, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:220427181
- GRCh38:
- Chr2:219562459
| OBSL1 | G966S | not provided, 3M syndrome 2 | Uncertain significance (Sep 22, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:220424196
- GRCh38:
- Chr2:219559474
| OBSL1 | P993S | 3M syndrome 2 | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr2:220424095
- GRCh38:
- Chr2:219559373
| OBSL1 | | not provided, 3M syndrome 2 | Conflicting interpretations of pathogenicity (Aug 6, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr2:220424046
- GRCh38:
- Chr2:219559324
| OBSL1 | R1043C | Inborn genetic diseases, not provided, 3M syndrome 2
| Uncertain significance (Jul 12, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:220422151
- GRCh38:
- Chr2:219557429
| OBSL1 | R1327Q | Inborn genetic diseases, not provided, 3M syndrome 2
| Uncertain significance (Oct 13, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:220422113
- GRCh38:
- Chr2:219557391
| OBSL1 | | 3M syndrome 2 | Uncertain significance (Mar 30, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr2:220420867
- GRCh38:
- Chr2:219556145
| OBSL1 | R1495H | Inborn genetic diseases, not provided, 3M syndrome 2
| Uncertain significance (Aug 9, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:220420730
- GRCh38:
- Chr2:219556008
| OBSL1 | V1541I | not provided, 3M syndrome 2 | Conflicting interpretations of pathogenicity (Jun 27, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr2:220419468
- GRCh38:
- Chr2:219554746
| OBSL1 | | not provided, 3M syndrome 2 | Uncertain significance (Jul 17, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:220430022
- GRCh38:
- Chr2:219565300
| OBSL1 | S783R | 3M syndrome 2 | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr2:220429979
- GRCh38:
- Chr2:219565257
| OBSL1 | G798S | Inborn genetic diseases, not provided, 3M syndrome 2
| Conflicting interpretations of pathogenicity (Aug 6, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr2:220429953
- GRCh38:
- Chr2:219565231
| OBSL1 | | not specified, 3M syndrome 2, not provided
| Conflicting interpretations of pathogenicity (Oct 24, 2023) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr2:220423133
- GRCh38:
- Chr2:219558411
| OBSL1 | H1092R | not provided, Inborn genetic diseases, 3M syndrome 2
| Uncertain significance (Aug 28, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:220423053
- GRCh38:
- Chr2:219558331
| OBSL1 | | 3M syndrome 2, not provided | Uncertain significance (Nov 1, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:220422993
- GRCh38:
- Chr2:219558271
| OBSL1 | T1139P | 3M syndrome 2 | Uncertain significance (Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr2:220421379
- GRCh38:
- Chr2:219556657
| OBSL1 | T1378M | 3M syndrome 2, Inborn genetic diseases, not provided
| Uncertain significance (Sep 1, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:220419222
- GRCh38:
- Chr2:219554500
| OBSL1 | R1617H | not provided, 3M syndrome 2 | Uncertain significance (Sep 13, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:220418335
- GRCh38:
- Chr2:219553613
| OBSL1 | | 3M syndrome 2 | Uncertain significance (Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr2:220435588
- GRCh38:
- Chr2:219570866
| OBSL1 | S123P | 3M syndrome 2, not provided, Inborn genetic diseases
| Uncertain significance (Nov 8, 2022) | criteria provided, multiple submitters, no conflicts |